Sun Pharma Advanced Research Q4FY21 loss at Rs. 56.72 Cr

Sun Pharma Advanced Research Q4FY21 loss at Rs. 56.72 Cr

By: IPP Bureau

Last updated : June 08, 2021 11:19 am



The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020


Sun Pharma Advanced Research Company Limited has reported total income of Rs.28.39 crores during the period ended March 31, 2021 as compared to Rs.23.41 crores during the period ended December 31, 2020.

The company has reported total income of Rs.25.83 crores during the period ended March 31, 2020.

Sun Pharma Advanced Research Company Limited has posted net loss of Rs. 56.72 crores for the period ended March 31, 2021 as against net loss of Rs. 67.62 crores for the period ended December 31, 2020.

The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020.

Sun Pharma Advanced Research Company Limited has reported total income of Rs.258.37 crores during the 12 months period ended March 31, 2021 as compared to Rs.86.58 crores during the 12 months period ended March 31, 2020.

Sun Pharma Advanced Research Company Limited has posted net profit / (loss) of Rs.(151.14) crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.(312.40) crores for the 12 months period ended March 31, 2020.

Sun Pharma Advanced Research Company Limited

First Published : May 18, 2021 12:00 am